98%
921
2 minutes
20
Introduction: Hemispherectomies, hemispherotomies, and lobectomies of the brain are neurosurgical techniques used to treat drug-resistant epilepsy (DRE). While effective for seizure control, these neurosurgical interventions can produce significant functional deficits including hemiparesis and iatrogenic cerebral palsy. In this study, we aimed to evaluate the resulting MSK pathology following surgery for DRE so that we may establish the incidence of new MSK pathology, identify risk factors for developing MSK pathology, and guide orthopaedic follow-up care.
Methods: A retrospective chart review of 168 paediatric patients who underwent a brain hemispherectomy, hemispherotomy, or lobectomy between 2009 and 2018 was performed. Data including pre-existing neurological and orthopaedic conditions, presence of MSK pathology that emerged post-neurosurgical procedure, documented referral to orthopaedics, and post-operative interventions were collected. A multivariate logistic regression model was used to correlate predictive variables with the risk for developing new MSK pathology.
Results: Of the 168 patients included, 45.2% (n = 76) developed a new MSK condition post-operatively. Of those with new MSK pathology, 30.3% (23) received orthopaedic follow-up. Of those, 34.8% (8) underwent a subsequent orthopaedic surgery. The median time to diagnosis of emerging MSK pathology following neurosurgical intervention was 0.7 months (range: 0-128 months), while the median time from emergence of symptoms to orthopaedic follow-up was 9.5 months (range: 2-161 months). Of the 28 patients who had MSK pathology prior to neurosurgical intervention, 42.8% (n = 12) were seen by orthopaedic providers following neurosurgery, of which 58.3% (n = 7) required orthopaedic surgery. Older age at the time of initial neurological surgery was significantly associated with decreased risk for developing new post-operative MSK pathology (OR 0.985, 95% CI: 0.979-0.911, p < 0.001), while repeat or revision neurosurgery was associated with increased risk (OR 3.728, 95% CI: 1.530-9.083, p < 0.01).
Conclusion: Paediatric patients who undergo hemispherectomies, hemispherotomies, or lobectomies for DRE are subject to a significant post-operative burden of MSK disease, yet less than 1/3 of newly-affected patients receive orthopaedic follow-up - highlighting a gap between the need for and provision of orthopaedic care in this population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000545112 | DOI Listing |
Prostate
September 2025
Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Background: Genomic instability is a key feature of cancer and plays a central role in tumor progression. One emerging metric for genomic instability is the fraction of genome altered (FGA), which quantifies the proportion of the genome affected by copy number alterations. Previous studies in various solid tumors have shown that high FGA is associated with aggressive disease and adverse clinical outcomes.
View Article and Find Full Text PDFGynecol Oncol
August 2025
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:
Objective: To define the structural variants, mutational signatures, and DNA repair defects in serous endometrial carcinoma (EC) using whole-genome sequencing (WGS).
Methods: Ten primary untreated classic serous ECs diagnosed between 2012 and 2018 were selected. Tumor and matched normal DNAs were subjected to WGS, and sequencing data were analyzed using state-of-the-art bioinformatics methods.
Bone Jt Open
August 2025
Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
Aims: To systematically review published evidence of outcomes reported in trials of knee injuries in children and adolescents.
Methods: We searched the following databases from inception to 29 July 2024: OVID MEDLINE, Embase, Cochrane CENTRAL, Clinicaltrials.gov, and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP).
Genes Chromosomes Cancer
August 2025
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Extraskeletal myxoid chondrosarcoma (EMC) is a rare mesenchymal neoplasm of uncertain histogenesis, characterized by recurrent gene fusions involving NR4A3 with various gene partners (EWSR1, TAF15, FUS, etc.). Although the impact of fusion variants has been linked to histology and prognosis, no study to date has comprehensively investigated the incidence and spectrum of secondary genetic alterations (SGAs) in EMC with regard to their association with fusion type and clinical impact.
View Article and Find Full Text PDFGynecol Oncol
August 2025
Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Slo
Objective: To characterize age-related variations in germline pathogenic variants (gPVs) in patients with high-grade serous ovarian cancer (HGSOC).
Methods: Patients with HGSOC who underwent clinical tumor-normal sequencing of ≥76 genes from 1/1/2015-11/15/2022, were included. Clinical variables including age at diagnosis were collected.